6
Oct
2026

Farmson Basic Drugs Pvt Ltd

Exhibitor at CPHI Milan 2026 stand 2A84, API
About Us

Founded in 1969, Farmson Basic Drug Pvt. Ltd. is a Vadodara-based global leader in Paracetamol API manufacturing, with a capacity of over 52,000 MTPA and a presence in more than 65 countries. As the only global company with end-to-end integration for Paracetamol production, Farmson is now expanding into caffeine manufacturing, with an initial monthly capacity of 600 MT.

  • Country/Region:
    India
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
Primary activities
API Producer
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 2A84, API

Products Featured at CPHI Milan 2026

  • Paracetamol / Acetaminophen

    Product Paracetamol / Acetaminophen

    Farmson Pharmaceutical Gujarat Pvt. Ltd is the only global pharmaceutical company with End to End integration in the production of Paracetamol, from backward integration ensuring a reliable and sustainable supply of raw material to forward integration into the manufacturing of Paracetamol DC (Dire...
  • Caffeine

    Product Caffeine

    Farmson is Manufacturing Caffeine with easily available raw materials (i.e. 2-Cyanoacetic acid and 1,3-Dimethylurea) in total 4 stages. i.e. we are measuring quality in each isolated intermediate and controlling impurities. We have capacity to manufacture 600 MT caffeine in a month. Farmson in manufact...
  • Levosalbutamol

    Product Levosalbutamol

    Levosalbutamol is a fast-acting bronchodilator that relaxes airway muscles, making it effective in treating asthma and chronic obstructive pulmonary disease (COPD).


  • Paracetamol DC

    Product Paracetamol DC

    Farmson offers comprehensive solutions, streamlining the process from Active Pharmaceutical Ingredients (API) to directly compressible tablet formulations. Our Directly Compressible (DC) granules facilitate drum-to-feeder tablet compression and encapsulation, providing cost-effective and operationally...
  • Rivaroxaban

    Product Rivaroxaban

    Rivaroxaban is a highly effective anticoagulant used in cardiovascular treatments to prevent and treat deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke in patients with atrial fibrillation.

FARMSON ANALGESICS Resources (1)